查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1701350

RNA靶向小分子藥物發現市場規模、佔有率、趨勢分析報告：按適應症、最終用途、地區、分部預測、分部預測，2025-2030年

RNA Targeting Small Molecule Drug Discovery Market Size, Share & Trends Analysis Report By Indication (Cancer, Infectious Diseases, Metabolic Diseases, Neurological Diseases), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

RNA靶向小分子藥物研發市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球RNA標靶小分子藥物研發市場規模預計到2030年將達到54.2億美元，2025年至2030年的複合年成長率為21.9%。

RNA 標靶小分子藥物研發產業因其有可能為多種疾病開發有效的標靶化治療方法而持續快速成長。

癌症、遺傳性疾病和病毒感染等疾病的日益流行，推動了對 RNA 靶向小分子藥物的需求。隨著 CRISPR-Cas9 和RNA干擾等最尖端科技的引入，RNA 標靶小分子藥物研發產業得到了顯著發展。這些技術使得識別與疾病發作有關的 RNA 標靶成為可能，並促進了針對 RNA 的全新小分子藥物的開發。

未來幾年，受製藥和生物技術公司研發活動支出增加的推動，用於藥物研發的 RNA 靶向小分子市場預計將大幅擴張。產生創新 RNA 標靶小分子的過程既費時又昂貴，但集中、高效治療帶來的潛在回報使其值得投資。

例如，Moderna於2020年與Vertex Pharmaceuticals合作開發用於治療囊腫纖維化的RNA標靶小分子藥物，就是對該領域的重大投資。 Moderna 將利用其 mRNA 技術平台來識別新的 RNA 靶點，而 Vertex 將運用其小分子藥物發現專業知識來開發針對這些標靶的治療方法。此次合作反映出人們對 RNA 標靶小分子藥物研發的興趣和投資日益成長，這有可能徹底改變疾病治療。

RNA標靶小分子藥物研發市場報告重點

  • 根據適應症，腫瘤學在預測期內將呈現最高的複合年成長率，為 22.3%。該領域的高成長很大程度上是由於癌症盛行率的不斷上升以及對更有效治療方法的迫切需求。
  • 在 RNA 靶向小分子藥物研發產業，製藥和生物製藥公司佔據最終用戶領域的主導地位，2024 年的市場佔有率為 59.4%。這是由於該領域對研發活動的大量投資以及將新藥推向市場的專業知識。
  • 預計到 2024 年，北美將佔據全球市場的最大收入佔有率，達到 60.7%，這得益於主要市場參與者的存在、先進的醫療保健基礎設施以及研發活動投資的增加等因素。該地區擁有完善的醫療保健體系，支持新治療方法的開發和商業化，這為其在該市場佔據優勢做出了貢獻。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章 RNA 標靶小分子藥物研發市場變數、趨勢與範圍

  • 市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析-波特五力分析
    • PESTLE分析

第4章 RNA 標靶小分子藥物研發市場：按適應症進行的業務分析

  • 2024年及2030年指示市場佔有率
  • 指示細分儀表板
  • 市場規模、預測與趨勢分析（2018-2030 年）
  • 癌症
  • 感染疾病
  • 代謝紊亂
  • 神經系統疾病
  • 其他

第5章 RNA 標靶小分子藥物研發市場：依最終用途進行的業務分析

  • 2024 年及 2030 年最終用途市場佔有率
  • 最終用途細分儀表板
  • 按最終用途分類的市場規模、預測和趨勢分析（2018-2030 年）
  • 製藥和生物製藥公司
  • 學術研究所
  • 其他

第6章 RNA 標靶小分子藥物研發市場：區域估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 市場規模、預測趨勢分析，2018 年至 2030 年：
  • 北美洲
    • 2018-2030年各國情況
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030年各國情況
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 2018-2030年各國情況
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018-2030年各國情況
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2018-2030年各國情況
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/列表
    • ACCENT THERAPEUTICS
    • Anima Biotech Inc.
    • Arrakis Therapeutics
    • AstraZeneca
    • Epics Therapeutics
    • Expansion Therapeutics
    • F. Hoffmann-La Roche Ltd
    • PTC Therapeutics, Inc.
    • Ribometrix
    • LES LABORATOIRES SERVIER
    • Skyhawk Therapeutics
Product Code: GVR-4-68040-049-3

RNA Targeting Small Molecule Drug Discovery Market Growth & Trends:

The global RNA targeting small molecule drug discovery market size is estimated to reach USD 5.42 billion by 2030, registering a CAGR of 21.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. RNA-targeting small molecule drug discovery industry continues to undergo rapid growth due to its potential to develop targeted and effective therapeutics for various diseases.

The increasing prevalence of diseases such as cancer, genetic disorders, and viral infections has fueled the demand for RNA-targeting small-molecule drugs. The RNA-targeting small molecule drug discovery industry has grown dramatically as a result of the introduction of cutting-edge technologies like CRISPR-Cas9 and RNA interference. These technologies have made it possible to identify RNA targets that are implicated in the pathogenesis of diseases, which has resulted in the creation of brand-new small-molecule medications that target RNA.

In the upcoming years, the market for RNA targeting small molecules for drug discovery is anticipated to experience significant expansion, driven by the rising expenditure in R&D activities by pharmaceutical and biotechnology businesses. The process of creating innovative, RNA-targeting small molecules is time-consuming and costly, but the potential rewards of focused, efficient treatments make it a worthy investment.

For instance, in 2020 Moderna's recent collaboration with Vertex Pharmaceuticals to develop RNA-targeted small molecule drugs for the treatment of cystic fibrosis is a significant investment in this field. Moderna will use its mRNA technology platform to identify novel RNA targets, while Vertex will apply its expertise in small molecule drug discovery to develop therapies for the targets. This collaboration reflects the growing interest and investment in RNA-targeting small molecule drug discovery, which has the potential to revolutionize disease treatment.

RNA Targeting Small Molecule Drug Discovery Market Report Highlights:

  • Cancer in the indication segment witnessed the highest CAGR of 22.3% ovre the forecast period. The high growth of the segment is majorly due to the increasing prevalence of cancer and the urgent need for more effective treatments.
  • Pharmaceutical and biopharmaceutical companies dominated the RNA-targeting small molecule drug discovery industry in the end-user segment, with a market share of 59.4% in 2024. This is due to their significant investment in research and development activities in this field, as well as their expertise in bringing new drugs to market.
  • North America held the maximum revenue share of 60.7% of the global market in 2024, due to factors such as the presence of key market players, advanced healthcare infrastructure, and increasing investment in research and development activities. This region has a well-established healthcare system that supports the development and commercialization of new therapies, which contributes to its dominance in the market.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Indication
    • 1.2.2. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. RNA Targeting Small Molecule Drug Discovery Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. RNA Targeting Small Molecule Drug Discovery Market: Indication Business Analysis

  • 4.1. Indication Market Share, 2024 & 2030
  • 4.2. Indication Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 4.4. Cancer
    • 4.4.1. Cancer Market, 2018 - 2030 (USD Million)
  • 4.5. Infectious Diseases
    • 4.5.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
  • 4.6. Metabolic Diseases
    • 4.6.1. Metabolic Diseases Market, 2018 - 2030 (USD Million)
  • 4.7. Neurological Diseases
    • 4.7.1. Neurological Diseases Market, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. RNA Targeting Small Molecule Drug Discovery Market: End Use Business Analysis

  • 5.1. End Use Market Share, 2024 & 2030
  • 5.2. End Use Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Pharmaceutical and Biopharmaceutical Companies
    • 5.4.1. Pharmaceutical and Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 5.5. Academic and Research Institutes
    • 5.5.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. RNA Targeting Small Molecule Drug Discovery Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. ACCENT THERAPEUTICS
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Anima Biotech Inc.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Arrakis Therapeutics
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. AstraZeneca
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Epics Therapeutics
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Expansion Therapeutics
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. F. Hoffmann-La Roche Ltd
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. PTC Therapeutics, Inc.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Ribometrix
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. LES LABORATOIRES SERVIER
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives
    • 7.5.11. Skyhawk Therapeutics
      • 7.5.11.1. Overview
      • 7.5.11.2. Financial Performance
      • 7.5.11.3. Product Benchmarking
      • 7.5.11.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global RNA targeting small molecule drug discovery market, by region, 2018 - 2030 (USD Million)
  • Table 4. Global RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 5. Global RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 6. North America RNA targeting small molecule drug discovery market, by country, 2018 - 2030 (USD Million)
  • Table 7. North America RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 8. North America RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 9. U.S. RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 10. U.S. RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 11. Canada RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 12. Canada RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 13. Mexico RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 14. Mexico RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 15. Europe RNA targeting small molecule drug discovery market, by country, 2018 - 2030 (USD Million)
  • Table 16. Europe RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 17. Europe RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 18. UK RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 19. UK RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 20. Germany RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 21. Germany RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 22. France RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 23. France RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 24. Italy RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 25. Italy RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 26. Spain RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 27. Spain RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 28. Norway RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 29. Norway RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 30. Denmark RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 31. Denmark RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 32. Sweden RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 33. Sweden RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific RNA targeting small molecule drug discovery market, by country, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 37. Japan RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 38. Japan RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 39. China RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 40. China RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 41. India RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 42. India RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 43. Australia RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 44. Australia RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 45. South Korea RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 46. South Korea RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 47. Thailand RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 48. Thailand RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 49. Latin America RNA targeting small molecule drug discovery market, by country, 2018 - 2030 (USD Million)
  • Table 50. Latin America RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 51. Latin America RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 52. Brazil RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 53. Brazil RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 54. Argentina RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 55. Argentina RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa RNA targeting small molecule drug discovery market, by country, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 58. Middle East & Africa RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 59. South Africa RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 60. South Africa RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 63. UAE RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 64. UAE RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 65. Kuwait RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 66. Kuwait RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 RNA targeting small molecule drug discovery market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Indication and end use outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 RNA targeting small molecule drug discovery market dynamics
  • Fig. 12 RNA targeting small molecule drug discovery market: Porter's five forces analysis
  • Fig. 13 RNA targeting small molecule drug discovery market: PESTLE analysis
  • Fig. 14 RNA targeting small molecule drug discovery market: Indication segment dashboard
  • Fig. 15 RNA targeting small molecule drug discovery market: Indication market share analysis, 2024 & 2030
  • Fig. 16 Cancer market, 2018 - 2030 (USD Million)
  • Fig. 17 Infectious diseases market, 2018 - 2030 (USD Million)
  • Fig. 18 Metabolic diseases market, 2018 - 2030 (USD Million)
  • Fig. 19 Neurological diseases market, 2018 - 2030 (USD Million)
  • Fig. 20 Others market, 2018 - 2030 (USD Million)
  • Fig. 21 RNA targeting small molecule drug discovery market: End use segment dashboard
  • Fig. 22 RNA targeting small molecule drug discovery market: End use market share analysis, 2024 & 2030
  • Fig. 23 Pharmaceutical and biopharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 24 Academic and research institutes market, 2018 - 2030 (USD Million)
  • Fig. 25 Others market, 2018 - 2030 (USD Million)
  • Fig. 26 RNA targeting small molecule drug discovery market revenue, by region
  • Fig. 27 Regional marketplace: Key takeaways
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 North America RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. country dynamics
  • Fig. 31 U.S. RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 32 Canada country dynamics
  • Fig. 33 Canada RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico country dynamics
  • Fig. 35 Mexico RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 37 UK country dynamics
  • Fig. 38 UK RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 39 Germany country dynamics
  • Fig. 40 Germany RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 41 France country dynamics
  • Fig. 42 France RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy country dynamics
  • Fig. 44 Italy RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain country dynamics
  • Fig. 46 Spain RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway country dynamics
  • Fig. 48 Norway RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden country dynamics
  • Fig. 50 Sweden RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark country dynamics
  • Fig. 52 Denmark RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 54 Japan country dynamics
  • Fig. 55 Japan RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 56 China country dynamics
  • Fig. 57 China RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 58 India country dynamics
  • Fig. 59 India RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 60 Australia country dynamics
  • Fig. 61 Australia RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea country dynamics
  • Fig. 63 South Korea RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand country dynamics
  • Fig. 65 Thailand RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil country dynamics
  • Fig. 68 Brazil RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina country dynamics
  • Fig. 70 Argentina RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 71 MEA RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 72 South Africa country dynamics
  • Fig. 73 South Africa RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 74 Saudi Arabia country dynamics
  • Fig. 75 Saudi Arabia RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 76 UAE country dynamics
  • Fig. 77 UAE RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 78 Kuwait country dynamics
  • Fig. 79 Kuwait RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 80 Company categorization
  • Fig. 81 Company market position analysis
  • Fig. 82 Strategic framework